Bostin Loyd (Drug Enforcement Administration)
| Tracking # |
22-01063-F |
| Multi Request | Bostin Loyd |
| Submitted | Sept. 2, 2022 |
| Est. Completion | None |
MuckRock users can file, duplicate, track, and share public records requests like this one. Learn more.
Communications
From: Anthony Roberts
To Whom It May Concern:
Pursuant to the Freedom of Information Act, I hereby request the following records:
All documents mentioning "Bostin Loyd" who was born on March 29, 1992 and who died on February 25, 2022 (links to online obituaries below).
The term "documents" should be defined as, but not be strictly limited to, court documents, testimony, court transcripts, expert reports, memoranda, interviews, memoranda of interviews, briefs, depositions, complaints, answers to complaints, interrogatories, emails, text messages, letters, files, subpoenas, warrants, search warrants, arrest warrants, petitions, affidavits, and all files of in any electronic format in this agency's possession. This should also be construed to include those documents submitted on his behalf by any person acting as a representative or agent on his behalf.
As illustrated by the quantity and content of the obituary links below, Mr. Loyd was a public figure and the public has a compelling interest in disclosure of the requested documents.
https://www.brewerfuneral.com/obituaries/Bostin-Loyd?obId=24109263
https://www.tributearchive.com/obituaries/24109263/bostin-loyd/wall
https://www.legacy.com/us/obituaries/name/bostin-loyd-obituary?id=33302292
https://muscleinsider.com/news/bodybuilder-bostin-loyd-dies-29
https://generationiron.com/bostin-loyd-cause-of-death/amp/
https://theancestory.com/bostin-loyd/
https://usdaynews.com/celebrities/celebrity-death/bostin-loyd-death-cause/amp/
https://www.thefocus.news/sports/bostin-loyd-death/?amp
https://therecenttimes.com/news/what-happened-to-bostin-loyd-bodybuilder-passes-away-at-29/amp
https://fitnessvolt.com/bostin-loyd-autopsy-report/
https://wikibiography.in/bostin-loyd-wiki-bio/
https://biographygist.com/bostin-loyd-passed-away-at-the-age-of-29/
I am a member of the media and these documents would be used to publicly disseminate the information found therein, and I would therefore request a fee waiver for the requested search and documents.
The requested documents will be made available to the general public, and this request is not being made for commercial purposes.
In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.
Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.
Sincerely,
Anthony Roberts
From: Drug Enforcement Administration
Dear Anthony Roberts,
The status of your FOIA request #22-01063-F has been updated to the following status 'Received'. To log into the DEA Public Access Link click on the Application URL below.
Sincerely,
DEA
From: Drug Enforcement Administration
Dear Anthony Roberts,
Case Number 22-01063-F has been assigned to the request you submitted. In all future correspondence regarding this request please reference case number 22-01063-F.
Regards,
DEA
From: Drug Enforcement Administration
Dear Anthony Roberts: This e-mail responds to your Freedom of Information Act/Privacy Act (FOIA/PA) request dated September 15, 2022, received by the Drug Enforcement Administration (DEA), FOIA/PA Unit, seeking access to DEA records. Your request has been opened and assigned the following case number: 22-01063-F. Please include this case number when communicating with this office. The records you seek require searches in another office or offices, and so your request falls within "unusual circumstances." See 5 U.S.C. § 552(a)(6)(B)(i)-(iii). Because of these unusual circumstances, we are extending the time limit to respond to your request beyond the ten additional days provided by the statute. We have not yet completed a search to determine whether there are records within the scope of your request. The time needed to process your request will necessarily depend on the complexity of our records search and on the volume and complexity of any records located. For your information, this office assigns incoming requests to one of three tracks: simple, complex, or expedited. Each request is then handled on a first-in, first-out basis in relation to other requests in the same track. Simple requests usually receive a response in approximately one month, whereas complex requests necessarily take longer. At this time, your request has been assigned to the complex track. You may wish to narrow the scope of your request to limit the number of potentially responsive records or agree to an alternative time frame for processing, should records be located; or you may wish to await the completion of our records search to discuss either of these options. We regret the necessity of this delay, but please be assured that your request will be processed as soon as possible. If you have any questions or wish to discuss reformulation or an alternative time frame for the processing of your request, you may contact FOIA/PA Unit representative Melanie M. Hoyos at (571) 776-3008 or via e-mail at Melanie.M.Hoyos@dea.gov, our FOIA Requester Service Center at (571) 776-2300, or e-mail your correspondence to DEA.FOIA@dea.gov. In addition, you may wish to visit our website at www.dea.gov to determine if the information you are requesting is already available to the public. You may contact our FOIA Public Liaison at (571) 776-2300 for any further assistance and to discuss any aspect of your request. Additionally, you may contact the Office of Government Information Services (OGIS) at the National Archives and Records Administration to inquire about the FOIA mediation services they offer. The contact information for OGIS is as follows: Office of Government Information Services, National Archives and Records Administration, Room 2510, 8601 Adelphi Road, College Park, Maryland 20740-6001; e-mail at ogis@nara.gov; telephone at (202) 741-5770; toll free at 1-877-684-6448; or facsimile at (202) 741-5769. Sincerely,
Melanie M. Hoyos FOIA/PA Specialist Intake Sub-Unit FOIA/PA Unit Drug Enforcement Administration Telephone: (571) 776-3008 E-mail: Melanie.M.Hoyos@dea.gov
PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal and privileged information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). Any use of this information by anyone other than the intended recipient is prohibited. If you have received this communication in error, please immediately delete all copies of this information and notify me by e-mail. The use, dissemination, distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful.
From: Drug Enforcement Administration
Dear Anthony Roberts: To retrieve the information that you may be seeking requires more specificity. Under the FOIA, an agency is not required to conduct research. DEA maintains several types of records and records systems (i.e., regulatory, personnel, investigative, etc.). For example, in your letter, you are requesting “all documents mentioning Bostin Loyd,” yet you have not specified a particular DEA office that you wish searched; or the type of record that would be responsive to your request. Be advised that DEA has 239 Domestic Offices in 23 Divisions throughout the United States, and 92 foreign offices in 69 countries, and more than 150 Headquarters Offices. Since your description did not limit the search to a specific office or area, a vast majority of DEA offices would be tasked to conduct a search of their respective offices for any responsive records pertaining to the subject of your request. As such, your request is overly broad and burdensome.
If you could please provide us with a response as to what types of records you are seeking in addition, please provide dates and specific locations in your response as well. If you could please reply within 5 business days. If you have any other questions, please feel free to reach out.
Sincerely, Melanie M. Hoyos FOIA/PA Specialist Intake Sub-Unit
FOIA/PA Unit Drug Enforcement Administration Telephone: (571) 776-3008 E-mail: Melanie.M.Hoyos@dea.gov PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal andprivileged information that requires protection in compliance with the PrivacyAct of 1974 (5 U.S.C. § 552a). Any useof this information by anyone other than the intended recipient is prohibited. If you have received this communication inerror, please immediately delete all copies of this information and notify meby e-mail. The use, dissemination,distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful.
From: Drug Enforcement Administration
Dear Anthony Roberts,
The status of your FOIA request #22-01063-F has been updated to the following status 'On Hold - Other'. To log into the DEA Public Access Link click on the Application URL below.
Sincerely,
DEA
From: Drug Enforcement Administration
Dear Anthony Roberts: I am following up on an email we sent to you on September 20, 2022 seeking clarification on what types of records you are seeking regarding your subject. If you can please reply to the email and let us know what types of records you are seeking. In addition, please provide locations and dates as well. If you could please reply within 5 business days. If you have any questions, please feel free to reach out. Sincerely, Melanie M. Hoyos FOIA/PA Specialist Intake Sub-Unit
FOIA/PA Unit Drug Enforcement Administration Telephone: (571) 776-3008 E-mail: Melanie.M.Hoyos@dea.gov PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal andprivileged information that requires protection in compliance with the PrivacyAct of 1974 (5 U.S.C. § 552a). Any useof this information by anyone other than the intended recipient is prohibited. If you have received this communication inerror, please immediately delete all copies of this information and notify meby e-mail. The use, dissemination,distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful.
From: Drug Enforcement Administration
Dear Anthony Roberts,
The status of your FOIA request #22-01063-F has been updated to the following status 'On Hold - Need Info/Clarification'. To log into the DEA Public Access Link click on the Application URL below.
Sincerely,
DEA
From: Anthony Roberts
Ms. Hoyos,
I phoned your office and left a voicemail, I would like to speak with you to narrow the FOIA request per your correspondence.
-Anthony
From: Drug Enforcement Administration
Dear Anthony Roberts: It was a pleasure speaking with you today, based on our conversation you stated you are seeking all investigative records related to the subject Bostin Loyd within the date range from January 2016- February 2022. If you could please just confirm the details of the amended search parameters so that we can move forward with processing your request. If you have any other questions, please feel free to reach out. Sincerely, Melanie M. Hoyos FOIA/PA Specialist Intake Sub-Unit
FOIA/PA Unit Drug Enforcement Administration Telephone: (571) 776-3008 E-mail: Melanie.M.Hoyos@dea.gov PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal andprivileged information that requires protection in compliance with the PrivacyAct of 1974 (5 U.S.C. § 552a). Any useof this information by anyone other than the intended recipient is prohibited. If you have received this communication inerror, please immediately delete all copies of this information and notify meby e-mail. The use, dissemination,distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful.
From: Anthony Roberts
I am confirming the conversation referenced below. -Anthony Roberts
Dear Anthony Roberts: It was a pleasure speaking with you today, based on our conversation you stated you are seeking all investigative records related to the subject Bostin Loyd within the date range from January 2016- February 2022. If you could please just confirm the details of the amended search parameters so that we can move forward with processing your request. If you have any other questions, please feel free to reach out. Sincerely, Melanie M. Hoyos FOIA/PA Specialist Intake Sub-Unit
FOIA/PA Unit Drug Enforcement Administration Telephone: (571) 776-3008 E-mail: Melanie.M.Hoyos@dea.gov PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal andprivileged information that requires protection in compliance with the PrivacyAct of 1974 (5 U.S.C. § 552a). Any useof this information by anyone other than the intended recipient is prohibited. If you have received this communication inerror, please immediately delete all copies of this information and notify meby e-mail. The use, dissemination,distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful.
From: Anthony Roberts
To Whom it may concern,
I was previously made aware that the FOIA officer handling my request was likely to transfer the project to another agent. As such, I would like to reiterate that the subject of the request was Bostin Loyd (deceased), and as the deceased was widely recognized by the public to be an expert in performance and/or image enhancing drugs (PEDS or PIEDS), this request is meant to encompass information referencing the deceased and those substances that fall under those categories (e.g., PEDs and PIEDs), including all anabolic steroids (aka: anabolic androgenic steroids, or “AAS”), growth hormone(aka: human Growth Hormone, or “GH,” and/or “hGH”), Insulin-like Growth Factor (aka: IGF-1, IGF-I, and/or Lr3IGF-1), Growth Hormone Releasing Peptides (GHRP) and Growth Factors and growth hormone secretagogues (including but not limited to CJC-1295, GHRP, GHRP-2, GHRP-6, MGF, MK-677/Ibutamoren, and Hexarelin), Selective Androgen Receptor Modulators (including but not limited to S1, S2, S3, S4, Ligandrol, Ostarine, Rad-140, MK-2866, YK-11, and LGD-4033), PPAR agonists (peroxisome proliferator-activated receptor agonists) such as GW 501516/Cardarine, thyroid medications (thyroxine, etc.) and beta-2 agonists (i.e., clenbuterol and albuterol).
As the subject is deceased, a release form requiring his signature is inappropriate. And again, as the subject was a recognized expert in the PEDs/PIEDs, which are DEA regulated substances under the Controlled Substance Act and Controlled Substance Analogue Enforcement Act, in addition to those acts which reference and incorporate the aforementioned acts, this FOIA request is properly and with appropriate specificity directed to the Drug Enforcement Administration. Finally, privacy concerns of the deceased regarding this request are outweighed by the fact that he was a public figure with relation to the substances specified in the request and the public’s interest in disclosure.
I have also left a phone message on the main FOIA mailbox and would appreciate a return call.
Thank you for your time and attention to this matter.
-Anthony
From: Drug Enforcement Administration
Dear Anthony Roberts,
The status of your FOIA request #22-01063-F has been updated to the following status 'In Process'. To log into the DEA Public Access Link click on the Application URL below.
Sincerely,
DEA
From: Drug Enforcement Administration
Dear Anthony Roberts:
We received your recent status update request regarding your Freedom of Information Act/Privacy Act (FOIA/PA) request 22-01063-F . You had spoken with our staff and had amended your request parameters to a ll investigative records related to the subject Bostin Loyd within the date range from January 2016 to February 2022, but our office had not received any written confirmation of your request clarification. Can you please confirm your reformulated request by replying to this e-mail in order for us to proceed with a records search? If you have any questions, please contact our FOIA Requester Service Center at (571) 776-2300. Thank you! Sincerely, Jenrette L. Nowaczynski FOIA/PA Specialist Intake Sub-Unit
FOIA/PA Unit Drug Enforcement Administration Telephone: (571) 776-3044 E-mail: Jenrette.L.Nowaczynski@dea.gov PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal andprivileged information that requires protection in compliance with the PrivacyAct of 1974 (5 U.S.C. § 552a). Any useof this information by anyone other than the intended recipient is prohibited. If you have received this communication inerror, please immediately delete all copies of this information and notify meby e-mail. The use, dissemination,distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful.
From: Drug Enforcement Administration
Dear Anthony Roberts: This e-mail is acknowledging receipt of your correspondence dated October 10, 2022 and December 4, 2022 regarding your Freedom of Information Act/Privacy Act (FOIA/PA) request 22-01063-F, confirming that you are seeking all investigative records related to the subject Bostin Loyd within the date range from January 2016 to February 2022 in reference to anabolic steroids. If you have any questions, please contact our FOIA Requester Service Center at (571) 776-2300. Sincerely, Jenrette L. Nowaczynski FOIA/PA Specialist Intake Sub-Unit
FOIA/PA Unit Drug Enforcement Administration Telephone: (571) 776-3044 E-mail: Jenrette.L.Nowaczynski@dea.gov PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal andprivileged information that requires protection in compliance with the PrivacyAct of 1974 (5 U.S.C. § 552a). Any useof this information by anyone other than the intended recipient is prohibited. If you have received this communication inerror, please immediately delete all copies of this information and notify meby e-mail. The use, dissemination,distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful.
From: Drug Enforcement Administration
Dear Anthony Roberts: This e-mail responds to your Freedom of Information Act/Privacy Act (FOIA/PA) request dated September 15, 2022, received by the Drug Enforcement Administration (DEA), FOIA/PA Unit, seeking access to DEA records.
We are in receipt of your inquiry dated February 7, 2023, regarding the status of your pending FOIA/PA request.
We apologize for the delay in responding to your request. DEA is among the top six of all Department of Justice components that receives the largest number of FOIA requests per year. DEA received 1,603 requests in Fiscal Year 2022, and we have limited personnel resources to process such requests. See Department of Justice Annual FOIA Reports available at https://www.justice.gov/oip/reports-1. We are experiencing a backlog of approximately 1,800 requests, which has impacted our ability to process your request in a timelier manner. Notwithstanding, your case is being processed.
Due to the large number of requests received by DEA for disclosure of records pursuant to the Acts, and due to the limited resources available to process such requests, DEA has adopted a "first-in, first-out" practice of processing all incoming requests. This policy complies with the decision in Open America v. Watergate Special Prosecution Force, 547 F.2d 605, (D.C. Cir. 1976), citing 5 U.S.C. 552 (a)(6)(C) and is applied consistently by DEA. Please be advised, your request is 1,741 out of 2,269 pending requests in our complex processing queue.
If you have any questions regarding this e-mail, you may contact FOIA/PA Unit representative Jenrette Nowaczynski via e-mail at Jenrette.L.Nowaczynski@dea.gov. Sincerely, Jenrette Nowaczynski FOIA/PA Specialist
Processing Sub-Unit FOIA/PA Unit Drug Enforcement Administration Telephone: (571) 776-3044 E-mail: Jenrette.L.Nowaczynski@dea.gov PRIVACY ACT NOTICE: This e-mail (including anyattachments herein) may contain personal and privileged information thatrequires protection in compliance with the Privacy Act of 1974 (5 U.S.C. §552a). Any use of this information by anyone other thanthe intended recipient is prohibited. If you have received this communication in error,please immediately delete all copies of this information and notify me bye-mail. The use, dissemination, distribution, orreproduction of this communication by unintended recipients is not authorizedand may be unlawful.
From: Drug Enforcement Administration
Dear Anthony Roberts,
The status of your FOIA request #22-01063-F has been updated to the following status 'Closed'. To log into the DEA Public Access Link click on the Application URL below.
Sincerely,
DEA
From: Drug Enforcement Administration
Dear Anthony Roberts: Please see the attached response to your Freedom of Information Act/Privacy Act (FOIA/PA) request 22-01063-F. If you have any questions, please contact our FOIA Requester Service Center at (571) 776-2300. Sincerely, Jenrette Nowaczynski FOIA/PA Specialist Intake Sub-Unit
FOIA/PA Unit Drug Enforcement Administration E-mail: Jenrette.L.Nowaczynski@dea.gov PRIVACY ACT NOTICE: This e-mail (including any attachments herein) may contain personal andprivileged information that requires protection in compliance with the PrivacyAct of 1974 (5 U.S.C. § 552a). Any useof this information by anyone other than the intended recipient is prohibited. If you have received this communication inerror, please immediately delete all copies of this information and notify meby e-mail. The use, dissemination,distribution, or reproduction of this communication by unintended recipients is not authorized and may be unlawful.
Files
pages